SEROTONERGIC NEURONS ARE NOT INVOLVED IN ACTION OF L-DOPA IN PARKINSONS-DISEASE

被引：59

作者：

MELAMED, E ^{[1
]}

HEFTI, F ^{[1
]}

LIEBMAN, J ^{[1
]}

SCHLOSBERG, AJ ^{[1
]}

WURTMAN, RJ ^{[1
]}

机构：

[1] MIT, DEPT NUTR & FOOD SCI, NEUROENDOCRINE REGULAT LAB, CAMBRIDGE, MA 02139 USA

来源：

NATURE | 1980年 / 283卷 / 5749期

关键词：

D O I：

10.1038/283772a0

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：772 / 774

页数：3

共 40 条

[1]

Barbeau A, 1962, MONOAMINES SYSTEME N, P247

[2] DECREASE OF CEREBRAL 5-HYDROXYTRYPTAMINE BY 3,4-DIHYDROXYPHENYLALANINE AFTER INHIBITION OF EXTRACEREBRAL DECARBOXYLASE [J].

BARTHOLINI, G ;

DAPRADA, M ;

PLETSCHER, A .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1968, 20 (03) :228-+

[3] VERTEILUNG DES 5-HYDROXYTRYPTAMINS (SEROTONIN) IM GEHIRN DES MENSCHEN UND SEIN VERHALTEN BEI PATIENTEN MIT PARKINSON-SYNDROM [J].

BERNHEIMER, H ;

BIRKMAYER, W ;

HORNYKIEWICZ, O .

KLINISCHE WOCHENSCHRIFT, 1961, 39 (20) :1056-+

[4]

BERTLER A, 1966, PHARMACOL REV, V18, P369

[5]

BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787

[6] L-DOPA INDUCED CHANGES IN CENTRAL MONOAMINE NEURONS AFTER PERIPHERAL DECARBOXYLASE INHIBITION [J].

BUTCHER, L ;

ENGEL, J ;

FUXE, K .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1970, 22 (04) :313-+

[7] DEVELOPMENTS IN PHARMACOLOGY AND THERAPEUTICS OF PARKINSONISM [J].

CALNE, DB .

ANNALS OF NEUROLOGY, 1977, 1 (02) :111-119

[8]

CHASE TN, 1972, NEUROLOGY, V22, P479, DOI 10.1212/WNL.22.5.479

[9] STEREOTYPED AND CIRCLING BEHAVIOR INDUCED BY DOPAMINERGIC AGONISTS AFTER LESIONS OF MIDBRAIN RAPHE NUCLEI [J].

COSTALL, B ;

NAYLOR, RJ .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1974, 29 (02) :206-222

[10] MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA [J].

COTZIAS, GC ;

PAPAVASI.PS ;

GELLENE, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07) :337-&

← 1 2 3 4 →